« Return to News | Technology Solutions

Almac launches COMPASS platform to improve clinical trial management

Wednesday, December 7, 2011 10:21 AM

Almac has launched of its new forecasting platform, COMPASS, which has been designed to improve the accuracy and efficiency of the supply inventory process during clinical studies. COMPASS provides benefits to clients by allowing the Supply Chain Manager to proactively direct the entire clinical supply chain, ultimately saving money that is often lost through inaccurate forecasting or overproduction of supplies.  

COMPASS allows the Supply Chain Manager to produce material forecasts for bulk product, finished goods, and packaging components. Typically a number of forecast scenarios are produced upfront using available data such as patient recruitment projections and protocol information. Clients can then select the most appropriate model to proceed with. 

COMPASS can update the material forecast throughout the maintenance phase of the trial based on actual patient usage data. This allows the Supply Chain Manager to then review the system outputs and evaluate production and distribution strategies to ensure they are inline with the forecast. 

COMPASS will be offered as part of Almac’s Supply Chain Management services at all sites and for customers of all sizes.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.